We are live on ! Find out more
SMTI icon

Sanara MedTech

53 hedge funds and large institutions have $45.2M invested in Sanara MedTech in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

25% more capital invested

Capital invested by funds: $36.1M → $45.2M (+$9.1M)

8.96% more ownership

Funds ownership: 12.78%21.74% (+9%)

9% less funds holding

Funds holding: 5853 (-5)

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
53
Holders Change
-5
Holders Change %
-8.62%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
9
Increased
22
Reduced
14
Closed
11
Calls
Puts
Net Calls
Net Calls Change

SMTI Hedge Fund Activity: Q4 2025 in Review

53 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2025, worth a combined $45.2M — up 25% from $36.1M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SMTI and 9 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 22 added.

The largest buyer was Baird Financial Group, opening a new position worth an estimated $19.6M. The largest seller was Nuveen, exiting entirely with an estimated $658K sold.

  • 53 institutional investors held Sanara MedTech (SMTI) as of Q4 2025, down from 58 in Q3 2025.
  • Funds reported $45.2M of Sanara MedTech stock for Q4 2025, up 25% quarter-over-quarter.
  • 9 funds opened new Sanara MedTech positions in Q4 2025 and 11 closed out, a net change of -2 holders.
  • The largest Sanara MedTech buyer in Q4 2025 was Baird Financial Group, an estimated $19.6M added.
  • The largest Sanara MedTech seller in Q4 2025 was Nuveen, an estimated $658K sold.

Based on aggregated 13F filings for Q4 2025.